Prescription GLP-1 medications arent available or affordable for everyone, and the promise of a lower-cost alternative like a patch can be very appealing
Learn: Which metrics actually matter (and what healthy ranges look like) Where revenue typically leaks in psychiatry billing When to handle billing in-house vs
Retatrutide is investigational and is not FDA-approved
The appetite suppression observed was described as profound, with energy intake reductions sustained throughout the trial period
Commenting on the guidance, Toni Brunning, vice president of the Royal College of Anaesthetists, said: We encourage patients to let their healthcare team know as early as possible in their peri-operative journey if theyre taking a GLP-1 or dual GIP/GLP-1 RA, as these medications wont necessarily show on hospital or GP records if theyve been purchased privately
Some GLP-1s are now approved for use in the treatment of obesity as well